Pharma Marketing
Bristol Myers Squibb continues its $1.5 billion cost-reduction plan with 79 additional layoffs in New Jersey, focusing on optimizing operations and reinvesting in R&D. Learn how this impacts the pharmaceutical industry amid patent expirations and evolving market pressures.